Fax: (011) 396 68592242
Original Article
You have full text access to this OnlineOpen article
High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk ewing sarcoma family tumors
The Bambino Gesù Children's Hospital experience
Article first published online: 10 MAR 2006
DOI: 10.1002/cncr.21780
Copyright © 2006 American Cancer Society
Additional Information
How to Cite
Milano, G. M., Cozza, R., Ilari, I., De Sio, L., Boldrini, R., Jenkner, A., De Ioris, M., Inserra, A., Dominici, C. and Donfrancesco, A. (2006), High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk ewing sarcoma family tumors. Cancer, 106: 1838–1845. doi: 10.1002/cncr.21780
Publication History
- Issue published online: 4 APR 2006
- Article first published online: 10 MAR 2006
- Manuscript Accepted: 2 NOV 2005
- Manuscript Revised: 28 OCT 2005
- Manuscript Received: 19 JUL 2005
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , , , , Toxicity of high-dose chemotherapy with etoposide, thiotepa and CY in treating poor-prognosis Ewing's sarcoma family tumors: the experience of the Bambino Gesù Children's Hospital, Bone Marrow Transplantation, 2010, 45, 8, 1274
- 2, Biology and treatment of malignant solid tumors in childhood, Update on Cancer Therapeutics, 2007, 2, 4, 177

1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470)